DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Siegel D, Martin T, Nooka A. et al.
Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies.
Haematologica 2013;
98 (11) 1753-1761
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.